Bortezomib, doxorubicin and dexamethasone association is an effective option for plasma cell leukemia induction therapy.
(Q46416585)
scientific article
scientific article
Language:
Current Data About
Bortezomib, doxorubicin and dexamethasone association is an effective option for plasma cell leukemia induction therapy.
other details